Manufacturer
Novo Nordisk NDC Codes
Finished products listed with the FDA under labeler names that contain “Novo Nordisk”.
Most-listed names
By number of FDA listings (strengths, forms and packages), not by sales.
Products
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Alhemoconcizumab | Concizumab 100 mg/mL | Injection, SolutionSubcutaneous | Novo Nordisk | 0169-2080 |
| Alhemoconcizumab | Concizumab 100 mg/mL | Injection, SolutionSubcutaneous | Novo Nordisk | 0169-2081 |
| Alhemoconcizumab | Concizumab 40 mg/mL | Injection, SolutionSubcutaneous | Novo Nordisk | 0169-2084 |
| Awiqliinsulin icodec-abae | Insulin icodec 700 U/mL | Injection, SolutionSubcutaneous | Novo Nordisk Pharmaceutical Industries, LP | 0169-3105 |
| Awiqliinsulin icodec-abae | Insulin icodec 700 U/mL | Injection, SolutionSubcutaneous | Novo Nordisk Pharmaceutical Industries, LP | 0169-3170 |
| Esperoctantihemophilic factor (recombinant), glycopegylated-exei | — | Kit | Novo Nordisk | 0169-8055 |
| Esperoctantihemophilic factor (recombinant), glycopegylated-exei | — | Kit | Novo Nordisk | 0169-8100 |
| Esperoctantihemophilic factor (recombinant), glycopegylated-exei | — | Kit | Novo Nordisk | 0169-8150 |
| Esperoctantihemophilic factor (recombinant), glycopegylated-exei | — | Kit | Novo Nordisk | 0169-8200 |
| Esperoctantihemophilic factor (recombinant), glycopegylated-exei | — | Kit | Novo Nordisk | 0169-8300 |
| Esperoctantihemophilic factor (recombinant), glycopegylated-exei | — | Kit | Novo Nordisk | 0169-8400 |
| Esperoctantihemophilic factor (recombinant), glycopegylated-exei | — | Kit | Novo Nordisk | 0169-8500 |
| Fiaspinsulin aspart injection | Insulin aspart 100 [iU]/mL | Injection, SolutionSubcutaneous | Novo Nordisk | 0169-3201 |
| Fiaspinsulin aspart injection | Insulin aspart 100 [iU]/mL | Injection, SolutionSubcutaneous | Novo Nordisk | 0169-3204 |
| Fiaspinsulin aspart injection | Insulin aspart 100 [iU]/mL | Injection, SolutionSubcutaneous | Novo Nordisk | 0169-3205 |
| Fiaspinsulin aspart | Insulin aspart 100 [iU]/mL | Injection, SolutionSubcutaneous | Novo Nordisk | 0169-3206 |
| Insulin Aspart | Insulin aspart 100 [iU]/mL | Injection, SolutionIntravenous, Subcutaneous | Novo Nordisk Pharma, Inc. | 73070-100 |
| Insulin Aspart | Insulin aspart 100 [iU]/mL | Injection, SolutionIntravenous, Subcutaneous | Novo Nordisk Pharma, Inc. | 73070-102 |
| Insulin Aspart | Insulin aspart 100 [iU]/mL | Injection, SolutionIntravenous, Subcutaneous | Novo Nordisk Pharma, Inc. | 73070-103 |
| Insulin Aspart Protamine and Insulin Aspart Mix 70/30insulin aspart | Insulin aspart 100 [iU]/mL | Injection, SuspensionSubcutaneous | Novo Nordisk Pharma, Inc. | 73070-200 |
| Insulin Aspart Protamine and Insulin Aspart Mix 70/30insulin aspart | Insulin aspart 100 [iU]/mL | Injection, SuspensionSubcutaneous | Novo Nordisk Pharma, Inc. | 73070-203 |
| Insulin Degludec | Insulin degludec 100 U/mL | Injection, SolutionSubcutaneous | Novo Nordisk Pharma, Inc. | 73070-400 |
| Insulin Degludec | Insulin degludec 100 U/mL | Injection, SolutionSubcutaneous | Novo Nordisk Pharma, Inc. | 73070-403 |
| Insulin Degludec | Insulin degludec 200 U/mL | Injection, SolutionSubcutaneous | Novo Nordisk Pharma, Inc. | 73070-503 |
| Insulin Diluting Medium for NovoLogwater injection | Water 1 mL/mL | Injection, SolutionIntravenous, Subcutaneous | Novo Nordisk | 0169-2001 |